Trump Says US Would Lift China Fentanyl Tariff If Xi Cracks Down
US President Donald Trump said he would cut all fentanyl-related tariffs on Chinese goods if Beijing cracks down on exports of the drug and precursor chemicals used to make it.
Trump said Friday he discussed the issue with Chinese President Xi Jinping during their summit in South Korea, adding that “China's working very hard and I really believe that they have an incentive.” Trump agreed to halve a 20% duty related to fentanyl in their meeting.
“As soon as we see that, we'll get rid of the other 10%,” Trump told reporters aboard Air Force One.
The president's comments preview another possible concession to China in their future trade talks.
The leaders agreed to a landmark truce this week, under which Trump dropped his threat to impose 100% tariffs on Chinese goods and paused fees on Chinese-made ships docking at US ports in addition to lowering the fentanyl tariff and other measures.
In exchange, Xi is rolling back plans to further tighten export limits on rare-earth magnets needed to make widely used consumer products and resuming purchases of US agricultural products, including soybeans.
The measures are meant to last one year, at which point the two sides will negotiate again.
“We're going to have a great relationship with him, I think, for a long period of time,” Trump told reporters, referring to Xi.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
